NEW YORK (GenomeWeb News) – Waters today reported a 3 percent decline in its third quarter revenues year over year, but the firm said that it sees a stabilization in its end markets after a difficult first half of the year.

The Milford, Mass.-based firm reported total revenues of $374 million for the three-month period ended Oct. 3, down from $386.3 million for Q3 2008. The firm said that 1 percent of that decline was due to adverse foreign currency translation.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.